Erik van den Berg: CEO of Memo Therapeutics

Episode 84

0:00-30:59

Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.

Publisher

BioBoss

Link

wyantsimboli.com/bioboss/erik-van-den-berg-ceo-of-memo-therapeutics

Published

October 27, 2025

Duration

31 min

Format

Podcast

Category

Issues · Science

Source

RSS feed

Host

John Simboli

B

BioBoss

@bioboss

#erikvanden #memotherapeutics #lifesciences #investing

The Nile